Add to ORKGHuman neural stem cell transplantation in ALS: initial results from a phase I trial ico2,3, Giada Sgaravizzi2, Massimo Projetti Pensi2,3, The latter and two additional patients refused PEG and invasive ventilation and died 8 months after surgery due to the progression of respiratory failure. The autopsies confirmed that this was related to the evolution of the disease. Mazzini et al. Journal of Translational Medicine (2015) 13:1
Amyotrophic lateral sclerosis is a devastating neurodegenerative disorder that results in motoneuron...
Transplantation of several types of stem cells (SC) for the treatment of amyotrophic lateral scleros...
Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration in the brain and...
We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, feta...
We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, feta...
AbstractAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder that is char...
Lidia Cova1, Vincenzo Silani21Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto...
Objective The first US Food and Drug Administration–approved clinical trial to treat amyotrophic ...
The main objective of this phase I trial was to assess the feasibility and safety of microtransplant...
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized b...
Transplantation of several types of stem cells (SC) for the treatment of amyotrophic lateral scleros...
: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by th...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106747/1/ana24113.pd
Given the lack of effective drug treatments for amyotrophic lateral sclerosis (ALS), compelling prec...
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease with no effective therapy. The n...
Amyotrophic lateral sclerosis is a devastating neurodegenerative disorder that results in motoneuron...
Transplantation of several types of stem cells (SC) for the treatment of amyotrophic lateral scleros...
Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration in the brain and...
We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, feta...
We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, feta...
AbstractAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder that is char...
Lidia Cova1, Vincenzo Silani21Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto...
Objective The first US Food and Drug Administration–approved clinical trial to treat amyotrophic ...
The main objective of this phase I trial was to assess the feasibility and safety of microtransplant...
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized b...
Transplantation of several types of stem cells (SC) for the treatment of amyotrophic lateral scleros...
: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by th...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106747/1/ana24113.pd
Given the lack of effective drug treatments for amyotrophic lateral sclerosis (ALS), compelling prec...
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease with no effective therapy. The n...
Amyotrophic lateral sclerosis is a devastating neurodegenerative disorder that results in motoneuron...
Transplantation of several types of stem cells (SC) for the treatment of amyotrophic lateral scleros...
Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration in the brain and...
